146 related articles for article (PubMed ID: 3307874)
21. Quinones are reduced by 6-tetrahydrobiopterin in human keratinocytes, melanocytes, and melanoma cells.
Schallreuter KU; Rokos H; Chavan B; Gillbro JM; Cemeli E; Zothner C; Anderson D; Wood JM
Free Radic Biol Med; 2008 Feb; 44(4):538-46. PubMed ID: 17997383
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
[TBL] [Abstract][Full Text] [Related]
23. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
24. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
[TBL] [Abstract][Full Text] [Related]
25. FAD semiquinone stability regulates single- and two-electron reduction of quinones by Anabaena PCC7119 ferredoxin:NADP+ reductase and its Glu301Ala mutant.
Anusevicius Z; Miseviciene L; Medina M; Martinez-Julvez M; Gomez-Moreno C; Cenas N
Arch Biochem Biophys; 2005 May; 437(2):144-50. PubMed ID: 15850554
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study.
Verrax J; Delvaux M; Beghein N; Taper H; Gallez B; Buc Calderon P
Free Radic Res; 2005 Jun; 39(6):649-57. PubMed ID: 16036343
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships in two-electron reduction of quinones.
Cenas N; Anusevicius Z; Nivinskas H; Miseviciene L; Sarlauskas J
Methods Enzymol; 2004; 382():258-77. PubMed ID: 15047107
[No Abstract] [Full Text] [Related]
28. Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.
Folkes LK; Christlieb M; Madej E; Stratford MR; Wardman P
Chem Res Toxicol; 2007 Dec; 20(12):1885-94. PubMed ID: 17941699
[TBL] [Abstract][Full Text] [Related]
29. Quinones as mutagens, carcinogens, and anticancer agents: introduction and overview.
Smith MT
J Toxicol Environ Health; 1985; 16(5):665-72. PubMed ID: 4093988
[TBL] [Abstract][Full Text] [Related]
30. [The structural membrane control of the reduction of exogenous quinones catalysed by mitochondrial 2-methyl-1,4-naphthoquinone reductase].
Konev SV; Sukhodolets IG; Volotovskiĭ ID; Titovets EP
Mol Biol (Mosk); 1982; 16(6):1279-83. PubMed ID: 7155143
[TBL] [Abstract][Full Text] [Related]
31. Tocopherol metabolism using thermochemolysis: chemical and biological properties of gamma-tocopherol, gamma-carboxyethyl-hydroxychroman, and their quinones.
Sachdeva R; Thomas B; Wang X; Ma J; Jones KH; Hatcher PG; Cornwell DG
Chem Res Toxicol; 2005 Jun; 18(6):1018-25. PubMed ID: 15962937
[TBL] [Abstract][Full Text] [Related]
32. An examination of quinone toxicity using the yeast Saccharomyces cerevisiae model system.
Rodriguez CE; Shinyashiki M; Froines J; Yu RC; Fukuto JM; Cho AK
Toxicology; 2004 Sep; 201(1-3):185-96. PubMed ID: 15297032
[TBL] [Abstract][Full Text] [Related]
33. Role of iron ion chelation by quinones in their reduction, OH-radical generation and lipid peroxidation.
Dikalov S; Alov P; Rangelova D
Biochem Biophys Res Commun; 1993 Aug; 195(1):113-9. PubMed ID: 8395821
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinones: nitric oxide synthase as a quinone reductase.
Kumagai Y; Nakajima H; Midorikawa K; Homma-Takeda S; Shimojo N
Chem Res Toxicol; 1998 Jun; 11(6):608-13. PubMed ID: 9625728
[TBL] [Abstract][Full Text] [Related]
35. Reactions of the semiquinone free radicals of anti-tumour agents with oxygen and iron complexes.
Butler J; Hoey BM; Swallow AJ
FEBS Lett; 1985 Mar; 182(1):95-8. PubMed ID: 3918891
[TBL] [Abstract][Full Text] [Related]
36. Free radicals in toxicology: redox cycling and NAD(P)H:quinone oxidoreductase.
Schulz WA; Eickelmann P; Sies H
Arch Toxicol Suppl; 1996; 18():217-22. PubMed ID: 8678798
[No Abstract] [Full Text] [Related]
37. The organization of the quinone pool.
Rich PR
Biochem Soc Trans; 1982 Dec; 10(6):482-4. PubMed ID: 6295833
[No Abstract] [Full Text] [Related]
38. Reaction kinetics of 4-methoxy ortho benzoquinone in relation to its mechanism of cytotoxicity: a pulse radiolysis study.
Land EJ; Cooksey CJ; Riley PA
Biochem Pharmacol; 1990 Mar; 39(6):1133-5. PubMed ID: 2322299
[TBL] [Abstract][Full Text] [Related]
39. Bioreductive activation of quinones: redox properties and thiol reactivity.
Wardman P
Free Radic Res Commun; 1990; 8(4-6):219-29. PubMed ID: 2191903
[TBL] [Abstract][Full Text] [Related]
40. Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA.
Sinha BK; Chignell CF
Chem Biol Interact; 1979 Dec; 28(2-3):301-8. PubMed ID: 549745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
